Nova Eye Medical Dividends and Buybacks
Dividend criteria checks 0/6
Nova Eye Medical does not have a record of paying a dividend.
Key information
n/a
Dividend yield
-21.6%
Buyback Yield
Total Shareholder Yield | -21.6% |
Future Dividend Yield | n/a |
Dividend Growth | n/a |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
We Think Nova Eye Medical (ASX:EYE) Can Afford To Drive Business Growth
Nov 04Nova Eye Medical Limited (ASX:EYE) Might Not Be As Mispriced As It Looks After Plunging 26%
Sep 22Take Care Before Diving Into The Deep End On Nova Eye Medical Limited (ASX:EYE)
Aug 06Nova Eye Medical Limited (ASX:EYE) Soars 29% But It's A Story Of Risk Vs Reward
Apr 18Is There An Opportunity With Nova Eye Medical Limited's (ASX:EYE) 43% Undervaluation?
Mar 26News Flash: Analysts Just Made A Captivating Upgrade To Their Nova Eye Medical Limited (ASX:EYE) Forecasts
Jan 19Further Upside For Nova Eye Medical Limited (ASX:EYE) Shares Could Introduce Price Risks After 38% Bounce
Dec 27We're Not Very Worried About Nova Eye Medical's (ASX:EYE) Cash Burn Rate
Sep 03Improved Revenues Required Before Nova Eye Medical Limited (ASX:EYE) Stock's 43% Jump Looks Justified
Apr 17Is Nova Eye Medical (ASX:EYE) In A Good Position To Invest In Growth?
Dec 16We Think Nova Eye Medical (ASX:EYE) Needs To Drive Business Growth Carefully
Aug 27Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if EYE's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if EYE's dividend payments have been increasing.
Dividend Yield vs Market
Nova Eye Medical Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (EYE) | n/a |
Market Bottom 25% (AU) | 2.6% |
Market Top 25% (AU) | 6.1% |
Industry Average (Medical Equipment) | 1.6% |
Analyst forecast (EYE) (up to 3 years) | n/a |
Notable Dividend: Unable to evaluate EYE's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate EYE's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate EYE's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as EYE has not reported any payouts.